<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35112786</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's-like signaling in brains of COVID-19 patients.</ArticleTitle><Pagination><StartPage>955</StartPage><EndPage>965</EndPage><MedlinePgn>955-965</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12558</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The mechanisms that lead to cognitive impairment associated with COVID-19 are not well understood.</AbstractText><AbstractText Label="METHODS">Brain lysates from control and COVID-19 patients were analyzed for oxidative stress and inflammatory signaling pathway markers, and measurements of Alzheimer's disease (AD)-linked signaling biochemistry. Post-translational modifications of the ryanodine receptor/calcium (Ca2<sup>+</sup> ) release channels (RyR) on the endoplasmic reticuli (ER), known to be linked to AD, were also measured by co-immunoprecipitation/immunoblotting of the brain lysates.</AbstractText><AbstractText Label="RESULTS">We provide evidence linking SARS-CoV-2 infection to activation of TGF-&#x3b2; signaling and oxidative overload. The neuropathological pathways causing tau hyperphosphorylation typically associated with AD were also shown to be activated in COVID-19 patients. RyR2 in COVID-19 brains demonstrated a "leaky" phenotype, which can promote cognitive and behavioral defects.</AbstractText><AbstractText Label="DISCUSSION">COVID-19 neuropathology includes AD-like features and leaky RyR2 channels could be a therapeutic target for amelioration of some cognitive defects associated with SARS-CoV-2 infection and long COVID.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reiken</LastName><ForeName>Steve</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5807-3574</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Cellular Biophysics, Clyde and Helen Wu Center for Molecular Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sittenfeld</LastName><ForeName>Leah</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cellular Biophysics, Clyde and Helen Wu Center for Molecular Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dridi</LastName><ForeName>Haikel</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cellular Biophysics, Clyde and Helen Wu Center for Molecular Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cellular Biophysics, Clyde and Helen Wu Center for Molecular Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cellular Biophysics, Clyde and Helen Wu Center for Molecular Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marks</LastName><ForeName>Andrew R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cellular Biophysics, Clyde and Helen Wu Center for Molecular Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019837">Ryanodine Receptor Calcium Release Channel</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019837" MajorTopicYN="N">Ryanodine Receptor Calcium Release Channel</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">calcium</Keyword><Keyword MajorTopicYN="N">ryanodine receptor</Keyword><Keyword MajorTopicYN="N">tau pathology</Keyword></KeywordList><CoiStatement>Columbia University and Andrew Marks own stock in ARMGO Pharma, Inc., a company developing compounds targeting RyR and have patents on Rycals. Steven Reiken has consulted for ARMGO Pharma, Inc. in the last 36 months. All other authors declare no competing interests or conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>3</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35112786</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="doi">10.1002/alz.12558</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen N, Zhou M, Dong X, et&#xa0;al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507&#x2010;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, et&#xa0;al. Association of cardiac injury with mortality in hospitalized patients with COVID&#x2010;19 in Wuhan, China. JAMA Cardiol. 2020;5:802&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et&#xa0;al. Olfactory transmucosal SARS&#x2010;CoV&#x2010;2 invasion as a port of central nervous system entry in individuals with COVID&#x2010;19. Nat Neurosci. 2021;24:168&#x2010;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W&#x2010;J, Liang W&#x2010;H, Zhao Y, et&#xa0;al. Comorbidity and its impact on 1590 patients with COVID&#x2010;19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547. 10.1183/13993003.00547-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00547-2020</ArticleId><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres Acosta MA, Singer BD. Pathogenesis of COVID&#x2010;19&#x2010;induced ARDS: implications for an ageing population. Eur Respir J. 2020;56:2002049. 10.1183/13993003.02049-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02049-2020</ArticleId><ArticleId IdType="pmc">PMC7397945</ArticleId><ArticleId IdType="pubmed">32747391</ArticleId></ArticleIdList></Reference><Reference><Citation>Arentz M, Yim E, Klaff L, et&#xa0;al. Characteristics and outcomes of 21 critically ill patients with COVID&#x2010;19 in Washington State. JAMA. 2020;323:1612&#x2013;1614. 10.1001/jama.2020.4326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4326</ArticleId><ArticleId IdType="pmc">PMC7082763</ArticleId><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y&#x2010;Y, Ma Y&#x2010;T, Zhang J&#x2010;Y, Xie X. COVID&#x2010;19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259&#x2010;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, et&#xa0;al. Nervous system involvement after infection with COVID&#x2010;19 and other coronaviruses. Brain Behav Immun. 2020;87:18&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, et&#xa0;al. Structure of the SARS&#x2010;CoV&#x2010;2 spike receptor&#x2010;binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2010;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou JJ, Movassaghi, M &amp; Gordy, D , et&#xa0;al. Neuropathology of COVID&#x2010;19 (neuro&#x2010;COVID): clinicopathological update. Free Neuropathol. 2021;Jan 18;2:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861505</ArticleId><ArticleId IdType="pubmed">33554218</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur KT, Miller EH, Glendinning MD, et&#xa0;al. COVID&#x2010;19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144:2696&#x2010;2708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia HP, Look DC, Shi L, et&#xa0;al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79:14614&#x2010;14621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1287568</ArticleId><ArticleId IdType="pubmed">16282461</ArticleId></ArticleIdList></Reference><Reference><Citation>Abiodun OA, Ola MS. Role of brain renin angiotensin system in neurodegeneration: an update. Saudi J Biol Sci. 2020;27:905&#x2010;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042626</ArticleId><ArticleId IdType="pubmed">32127770</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhadian SF, Seilhean D, Spudich S. Neuropathogenesis of acute coronavirus disease 2019. Curr Opin Neurol. 2021;34:417&#x2010;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">33852526</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforge M, Elbim C, Fr&#xe8;re C, et&#xa0;al. Tissue damage from neutrophil&#x2010;induced oxidative stress in COVID&#x2010;19. Nat Rev Immunol. 2020;20:515&#x2010;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388427</ArticleId><ArticleId IdType="pubmed">32728221</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID&#x2010;19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355&#x2010;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Shen C, Li J, et&#xa0;al. Plasma IP&#x2010;10 and MCP&#x2010;3 levels are highly associated with disease severity and predict the progression of COVID&#x2010;19. J Allergy Clin Immunol. 2020;146:119&#x2010;127.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7189843</ArticleId><ArticleId IdType="pubmed">32360286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao R, Hernandez K, Huang L, Luke JJ. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS&#x2010;CoV&#x2010;2 COVID&#x2010;19. J Immunother Cancer. 2020;8:e001020 10.1136/jitc-2020-001020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-001020</ArticleId><ArticleId IdType="pmc">PMC7372174</ArticleId><ArticleId IdType="pubmed">32675312</ArticleId></ArticleIdList></Reference><Reference><Citation>Delpino MV, Quarleri J. SARS&#x2010;CoV&#x2010;2 Pathogenesis: imbalance in the renin&#x2010;angiotensin system favors lung fibrosis. Front Cell Infect Microbiol. 2020;10:340 10.3389/fcimb.2020.00340.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00340</ArticleId><ArticleId IdType="pmc">PMC7303284</ArticleId><ArticleId IdType="pubmed">32596170</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrati C, Sacchi A, Bordoni V, et&#xa0;al. Expansion of myeloid&#x2010;derived suppressor cells in patients with severe coronavirus disease (COVID&#x2010;19). Cell Death Differ. 2020;27:3196&#x2010;3207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7278239</ArticleId><ArticleId IdType="pubmed">32514047</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Zhang Y&#x2010;D, Zhou J&#x2010;S, et&#xa0;al. Angiotensin&#x2010;(1&#x2010;7) is reduced and inversely correlates with tau hyperphosphorylation in animal models of Alzheimer's disease. Mol Neurobiol. 2016;53:2489&#x2010;2497.</Citation><ArticleIdList><ArticleId IdType="pubmed">26044748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehoe PG, Wong S, Al Mulhim N, Palmer LE, Miners JS. Angiotensin&#x2010;converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid&#x2010;beta and tau pathology. Alzheimers Res Ther. 2016;8:50. 10.1186/s13195-016-0217-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-016-0217-7</ArticleId><ArticleId IdType="pmc">PMC5123239</ArticleId><ArticleId IdType="pubmed">27884212</ArticleId></ArticleIdList></Reference><Reference><Citation>Matecki S, Dridi H, Jung B, et&#xa0;al. Leaky ryanodine receptors contribute to diaphragmatic weakness during mechanical ventilation. Proc Natl Acad Sci USA. 2016;113:9069&#x2010;9074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987795</ArticleId><ArticleId IdType="pubmed">27457930</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacampagne A, Liu X, Reiken S, et&#xa0;al. Post&#x2010;translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease&#x2010;like pathologies and cognitive deficits. Acta Neuropathol. 2017;134:749&#x2010;767.</Citation><ArticleIdList><ArticleId IdType="pubmed">28631094</ArticleId></ArticleIdList></Reference><Reference><Citation>Dridi H, Liu X, Yuan Q, et&#xa0;al. Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease. JCI Insight. 2020;5:140614. 10.1172/jci.insight.140614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140614</ArticleId><ArticleId IdType="pmc">PMC7566717</ArticleId><ArticleId IdType="pubmed">32897880</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Betzenhauser MJ, Reiken S, et&#xa0;al. Role of leaky neuronal ryanodine receptors in stress&#x2010;induced cognitive dysfunction. Cell. 2012;150:1055&#x2010;1067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3690518</ArticleId><ArticleId IdType="pubmed">22939628</ArticleId></ArticleIdList></Reference><Reference><Citation>Dridi H, Kushnir A, Zalk R, Yuan Q, Melville Z, Marks AR. Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target. Nat Rev Cardiol. 2020;17:732&#x2010;747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362847</ArticleId><ArticleId IdType="pubmed">32555383</ArticleId></ArticleIdList></Reference><Reference><Citation>Dridi H, Wu W, Reiken SR, et&#xa0;al. Ryanodine receptor remodeling in cardiomyopathy and muscular dystrophy caused by lamin A/C gene mutation. Hum Mol Genet. 2021;29:3919&#x2010;3934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906753</ArticleId><ArticleId IdType="pubmed">33388782</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie W, Santulli G, Reiken SR, et&#xa0;al. Mitochondrial oxidative stress promotes atrial fibrillation. Sci Rep. 2015;5:11427 10.1038/srep11427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11427</ArticleId><ArticleId IdType="pmc">PMC4501003</ArticleId><ArticleId IdType="pubmed">26169582</ArticleId></ArticleIdList></Reference><Reference><Citation>Waning DL, Mohammad KS, Reiken S, et&#xa0;al. Excess TGF&#x2010;beta mediates muscle weakness associated with bone metastases in mice. Nat Med. 2015;21:1262&#x2010;1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4636436</ArticleId><ArticleId IdType="pubmed">26457758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Nicholls JM, Chen Y&#x2010;G. Severe acute respiratory syndrome&#x2010;associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor&#x2010;beta signaling. J Biol Chem. 2008;283:3272&#x2010;3280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8740907</ArticleId><ArticleId IdType="pubmed">18055455</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID&#x2010;19 pathogenesis. Mitochondrion. 2020;54:1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837003</ArticleId><ArticleId IdType="pubmed">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta D, Leslie SN, Wang M, et&#xa0;al. Age&#x2010;related calcium dysregulation linked with tau pathology and impaired cognition in non&#x2010;human primates. Alzheimers Dement. 2021;17:920&#x2010;932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195842</ArticleId><ArticleId IdType="pubmed">33829643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, et&#xa0;al. Dysregulation of brain and choroid plexus cell types in severe COVID&#x2010;19. Nature. 2021;595:565&#x2010;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil N. Regulation of the effects of TGF&#x2010;beta 1 by activation of latent TGF&#x2010;beta 1 and differential expression of TGF&#x2010;beta receptors (T beta R&#x2010;I and T beta R&#x2010;II) in idiopathic pulmonary fibrosis. Thorax. 2001;56:907&#x2010;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1745982</ArticleId><ArticleId IdType="pubmed">11713352</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnsten AFT, Wang M. The evolutionary expansion of mGluR3&#x2010;NAAG&#x2010;GCPII signaling: relevance to human intelligence and cognitive disorders. Am J Psychiatry. 2020;177:1103&#x2010;1106.</Citation><ArticleIdList><ArticleId IdType="pubmed">33256450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hof PR, Morrison JH. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp Neurol. 1991;111:293&#x2010;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">1999232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastianelli E. Distribution of calcium&#x2010;binding proteins in the cerebellum. Cerebellum. 2003;2:242&#x2010;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">14964684</ArticleId></ArticleIdList></Reference><Reference><Citation>Maguire&#x2010;Zeiss KA, Li ZW, Shimodal LMN, Hamill RW. Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects. Brain Res Mol Brain Res. 1995;30:362&#x2010;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">7637586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo H, Tanaka K, Hashikawa T, Jones EG. Neurochemical gradients along monkey sensory cortical pathways: calbindin&#x2010;immunoreactive pyramidal neurons in layers II and III. Eur J Neurosci. 1999;11:4197&#x2010;4203.</Citation><ArticleIdList><ArticleId IdType="pubmed">10594645</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel JC, Perez SE, Malek&#x2010;Ahmadi M, Mufson EJ. Cerebellar calcium&#x2010;binding protein and neurotrophin receptor defects in down syndrome and alzheimer's disease. Front Aging Neurosci. 2021;13:645334 10.3389/fnagi.2021.645334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.645334</ArticleId><ArticleId IdType="pmc">PMC7994928</ArticleId><ArticleId IdType="pubmed">33776745</ArticleId></ArticleIdList></Reference><Reference><Citation>Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S. The chronic neuropsychiatric sequelae of COVID&#x2010;19: the need for a prospective study of viral impact on brain functioning. Alzheimers Dement. 2021;17:1056&#x2010;1065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10431934</ArticleId><ArticleId IdType="pubmed">33399270</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekosky ST, Kochanek PM, Valadka AB, et&#xa0;al. Blood biomarkers for detection of brain injury in COVID&#x2010;19 patients. J Neurotrauma. 2021;38:1&#x2010;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7757533</ArticleId><ArticleId IdType="pubmed">33115334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermis U, Rust MI, Bungenberg J, et&#xa0;al. Neurological symptoms in COVID&#x2010;19: a cross&#x2010;sectional monocentric study of hospitalized patients. Neurol Res Pract. 2021;3:17. 10.1186/s42466-021-00116-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-021-00116-1</ArticleId><ArticleId IdType="pmc">PMC7953515</ArticleId><ArticleId IdType="pubmed">33712089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Kee Kwong KC, Mehta PR, Shukla G, Mehta AR. COVID&#x2010;19, SARS and MERS: a neurological perspective. J Clin Neurosci. 2020;77:13&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198407</ArticleId><ArticleId IdType="pubmed">32417124</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X, Blancett CD, Koistinen KA, et&#xa0;al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat Microbiol. 2017;2:17113. 10.1038/nmicrobiol.2017.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2017.113</ArticleId><ArticleId IdType="pubmed">28715405</ArticleId></ArticleIdList></Reference><Reference><Citation>Billioux BJ, Smith B, Nath A. Neurological complications of ebola virus infection. Neurotherapeutics. 2016;13:461&#x2010;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4965419</ArticleId><ArticleId IdType="pubmed">27412684</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Kim DJ, Takahashi T, et&#xa0;al. Kynurenic acid may underlie sex&#x2010;specific immune responses to COVID&#x2010;19. Sci Signal. 2021;14. 10.1126/scisignal.abf8483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abf8483</ArticleId><ArticleId IdType="pmc">PMC8432948</ArticleId><ArticleId IdType="pubmed">34230210</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz JA, et&#xa0;al. COVID&#x2010;19 infection alters kynurenine and fatty acid metabolism, correlating with IL&#x2010;6 levels and renal status. JCI Insight. 2020;5. 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler NG, Gray N, Kimhofer T, et&#xa0;al. Systemic perturbations in amine and kynurenine metabolism associated with acute SARS&#x2010;CoV&#x2010;2 infection and inflammatory cytokine responses. J Proteome Res. 2021;20:2796&#x2010;2811.</Citation><ArticleIdList><ArticleId IdType="pubmed">33724837</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka M, Fujisaki N, Maruko&#x2010;Otake A, et&#xa0;al. Ca2+/calmodulin&#x2010;dependent protein kinase II promotes neurodegeneration caused by tau phosphorylated at Ser262/356 in a transgenic Drosophila model of tauopathy. J Biochem. 2017;162:335&#x2010;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5892399</ArticleId><ArticleId IdType="pubmed">28992057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J&#x2010;Z, Grundke&#x2010;Iqbal I, Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci. 2007;25:59&#x2010;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3191918</ArticleId><ArticleId IdType="pubmed">17241267</ArticleId></ArticleIdList></Reference><Reference><Citation>Deture MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019;14:32. 10.1186/s13024-019-0333-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0333-5</ArticleId><ArticleId IdType="pmc">PMC6679484</ArticleId><ArticleId IdType="pubmed">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushnir A, Todd JJ, Witherspoon JW, et&#xa0;al. Intracellular calcium leak as a therapeutic target for RYR1&#x2010;related myopathies. Acta Neuropathol. 2020;139:1089&#x2010;1104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7788518</ArticleId><ArticleId IdType="pubmed">32236737</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx SO, Reiken S, Hisamatsu Y, et&#xa0;al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365&#x2010;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">10830164</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan J, Betzenhauser MJ, Kushnir A, et&#xa0;al. Role of chronic ryanodine receptor phosphorylation in heart failure and beta&#x2010;adrenergic receptor blockade in mice. J Clin Invest. 2010;120:4375&#x2010;4387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993577</ArticleId><ArticleId IdType="pubmed">21099115</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinger AM, Reiken S, Carlson C, et&#xa0;al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med. 2009;15:325&#x2010;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2910579</ArticleId><ArticleId IdType="pubmed">19198614</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga L, Ali H, Secco I, et&#xa0;al. Drugs that inhibit TMEM16 proteins block SARS&#x2010;CoV&#x2010;2 spike&#x2010;induced syncytia. Nature. 2021;594:88&#x2010;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611055</ArticleId><ArticleId IdType="pubmed">33827113</ArticleId></ArticleIdList></Reference><Reference><Citation>Danta CC. SARS&#x2010;CoV&#x2010;2, Hypoxia, and Calcium Signaling: the Consequences and Therapeutic Options. ACS Pharmacol Transl Sci. 2021;4:400&#x2010;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805596</ArticleId><ArticleId IdType="pubmed">33615190</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnsten AFT, Datta D, Del Tredici K, Braak H. Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer's disease. Alzheimers Dement. 2021;17:115&#x2010;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983919</ArticleId><ArticleId IdType="pubmed">33075193</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrens XHT, Lehnart SE, Reiken SR, et&#xa0;al. Protection from cardiac arrhythmia through ryanodine receptor&#x2010;stabilizing protein calstabin2. Science. 2004;304:292&#x2010;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">15073377</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>